Clinically Approved Antibiotics from 2010 to 2022

Authors

DOI:

https://doi.org/10.2533/chimia.2023.230

PMID:

38047802

Keywords:

Antibiotics, Antimicrobial resistance, Natural products, Semisynthesis, Tuberculosis

Abstract

This review discusses small molecule antibiotics approved for clinical use in the time frame 2010-2022. This time span saw the approval of four synthetic antibiotics (bedaquiline, pretomanid, delafloxacin, tedizolid), nine natural product derivatives (ceftaroline fosamil, cefiderocol, plazomicin, omadacycline, eravacycline, sarecycline, lefamulin, dalbavancin, oritavancin), and one natural product (fidaxomicin).

Funding data

CHIMIA Vol. 77 No. 4 (2023): Laureates: Junior Prizes of the Fall Meeting 2022

Downloads

Published

2023-04-26

Issue

Vol. 77 No. 4 (2023): Laureates: Junior Prizes of the Fall Meeting 2022

Section

Scientific Articles

License

Copyright (c) 2023 Erik Jung, Karl Gademann

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
E. Jung, K. Gademann, Chimia 2023, 77, 230, DOI: 10.2533/chimia.2023.230.